|
Market Closed -
CBOE
19:00:00 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 8,641.79 HUF | 0.00% |
|
0.00% | +1.07% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
| Market Cap | 2,253B 6.9B 6.16B 5.73B 5.21B 9.85B 668B 9.89B 69B 27.03B 340B 25.91B 25.34B 1,093B | P/E 2026 * |
9.09x | P/E 2027 * | 7.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1,990B 6.1B 5.44B 5.06B 4.61B 8.7B 590B 8.74B 60.96B 23.88B 301B 22.89B 22.39B 965B | EV / Sales 2026 * |
2.09x | EV / Sales 2027 * | 1.8x |
| Free-Float |
72.87% | Yield 2026 * |
4.89% | Yield 2027 * | 5.48% |
| Markets | Quality | ||
|---|---|---|---|
Budapest S.E.
| RICHTER | Delayed | |
OTC Markets
| RGEDF | Delayed | |
Boerse Muenchen
| RIG2 | Real-time | |
CBOE
| Real-time | ||
Deutsche Boerse AG
| RIG2 | Delayed | |
London S.E.
| 0QFP | Delayed | |
CBOE
| 0QFP | Real-time | |
Börse Stuttgart
| RIG2 | Delayed |
Last Transcript: Gedeon Richter PLC
| 6 months | +1.07% | ||
| Current year | +1.07% |
| 1 week | 8,641.79 | 8,641.79 | |
| 1 month | 8,641.79 | 8,641.79 | |
| 3 years | 8,041 | 9,720 | |
| 5 years | 8,041 | 9,720 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gábor Orbán
CEO | Chief Executive Officer | 47 | 01/11/2017 |
| Director of Finance/CFO | - | 01/05/2025 | |
Attila Szénási
COO | Chief Operating Officer | - | 01/01/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Erik Bogsch
CHM | Chairman | 79 | 01/01/2017 |
Szilveszter Vizi
CHM | Chairman | 90 | 01/03/2024 |
| Director/Board Member | 65 | 26/04/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +1.07% | +1.07% | 6.81B | ||
| +0.83% | +3.19% | +37.87% | +106.25% | 1,043B | ||
| +1.93% | +2.11% | +36.82% | +64.90% | 618B | ||
| +1.49% | +5.19% | +19.84% | +85.41% | 481B | ||
| +2.26% | +0.90% | +66.40% | +39.33% | 351B | ||
| +1.45% | +2.52% | +22.83% | +44.22% | 338B | ||
| +1.17% | +0.88% | +11.83% | +34.76% | 269B | ||
| +0.89% | -0.28% | -6.31% | +9.65% | 244B | ||
| +1.82% | +2.94% | +40.43% | +52.78% | 220B | ||
| +2.77% | +4.44% | +29.49% | +101.40% | 182B | ||
| Average | +1.73% | +0.28% | +26.03% | +53.98% | 416.3B | |
| Weighted average by Cap. | +1.48% | +0.60% | +31.64% | +69.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 951B 2.91B 2.6B 2.42B 2.2B 4.16B 282B 4.18B 29.14B 11.42B 144B 10.94B 10.7B 461B | 1,021B 3.13B 2.79B 2.6B 2.36B 4.46B 303B 4.48B 31.27B 12.25B 154B 11.74B 11.49B 495B |
| Net income | 254B 779M 696M 647M 589M 1.11B 75.39B 1.12B 7.79B 3.05B 38.44B 2.93B 2.86B 123B | 291B 890M 795M 739M 673M 1.27B 86.14B 1.28B 8.9B 3.49B 43.92B 3.34B 3.27B 141B |
| Net Debt | -262B -804M -718M -668M -608M -1.15B -77.81B -1.15B -8.04B -3.15B -39.67B -3.02B -2.95B -127B | -410B -1.26B -1.12B -1.04B -949M -1.79B -122B -1.8B -12.56B -4.92B -61.97B -4.72B -4.61B -199B |
| Date | Price | Change |
|---|---|---|
| 09/10/26 | HUF 8,641.79 | 0.00% |
| 08/10/26 | HUF 8,641.79 | 0.00% |
| 07/10/26 | HUF 8,641.79 | 0.00% |
| 06/10/26 | HUF 8,641.79 | 0.00% |
| 05/10/26 | HUF 8,641.79 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RICHTER Stock
- 0QFP Stock
Select your edition
All financial news and data tailored to specific country editions

















